176
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The correlation between birth weight and insulin-like growth factor-binding protein-1 (IGFBP-1), kisspeptin-1 (KISS-1), and three-dimensional fetal volume

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2152-2158 | Received 06 Oct 2017, Accepted 10 Jan 2018, Published online: 24 Jan 2018

References

  • Gibson JM, Aplin JD, White A, et al. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod. 2001;7(1):79–87.
  • Fowler DJ, Nicolaides KH, Miell JP. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update. 2000;6(5):495–504.
  • Chiesa C, Osborn JF, Haass C, et al. Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry? Clin Chem. 2008;54(3):550–558.
  • Elhddad AS, Lashen H. Fetal growth in relation to maternal and fetal IGF-axes: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2013;92(9):997–1006.
  • Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol. 1996;148(2):303–309.
  • Jansson N, Nilsfelt A, Gellerstedt M, et al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr. 2008;87(6):1743–1749.
  • Verhaeghe J, Pintiaux A, Van Herck E, et al. Placental GH, IGF-I, IGF-binding protein-1, and leptin during a glucose challenge test in pregnant women: relation with maternal body weight, glucose tolerance, and birth weight. J Clin Endocrinol Metab. 2002;87(6):2875–2882.
  • Armstrong RA, Reynolds RM, Leask R, et al. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagn. 2009;29(10):982–985.
  • Logie JJ, Denison FC, Riley SC, et al. Evaluation of kisspeptin levels in obese pregnancy as a biomarker for pre-eclampsia. Clin Endocrinol (Oxf). 2012;76(6):887–893.
  • Smets EM, Deurloo KL, Go AT, et al. Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates. Prenat Diagn. 2008;28(4):299–303.
  • Gaafar HM, Abdel Moety GAF, El-Khayat W. Three-dimensional ultrasonography using the VOCAL technique for estimation of reference range between 7 and 11 weeks embryonic volume. Middle East Fertil Soc J. 2013;18(2):115–119.
  • Riccabona M, Nelson TR, Pretorius DH. Three-dimensional ultrasound: accuracy of distance and volume measurements. Ultrasound Obstet Gynecol. 1996;7(6):429–434.
  • Fenton TR. A new growth chart for preterm babies: Babson and Benda’s chart updated with recent data and a new format. BMC Pediatr. 2003;3:13.
  • Falcon O, Peralta CFA, Cavoretto P, et al. Fetal trunk and head volume in chromosomally abnormal fetuses at 11° to 136 weeks of gestation. Ultrasound Obstet Gynecol. 2005;26(5):517–520.
  • Martins WP, Nastri CO, Barra DA, et al. Fetal volume and crown-rump length from 7 to 10 weeks of gestational age in singletons and twins. Eur J Obstet Gynecol Reprod Biol. 2009;145(1):32–35.
  • Papastefanou I, Kappou D, Souka AP, et al. Fetal volume at 11–14 gestational weeks: reference ranges and association with first trimester biochemical and biophysical markers. J Perinat Med. 2014;42(1):107–112.
  • Vafaei H, Samsami A, Zolghadri J, et al. Correlation of first-trimester fetal crown–rump length with outcome of pregnancy and birth weight. Int J Gynecol Obstet. 2012;119(2):141–144.
  • Van Uitert EM, Exalto N, Burton GJ, et al. Human embryonic growth trajectories and associations with fetal growth and birthweight. Hum Reprod. 2013;28(7):1753–1761.
  • Antsaklis A, Anastasakis E, Komita O, et al. First trimester 3D volumetry. Association of the gestational volumes with the birth weight. J Matern Fetal Neonatal Med. 2011;24(8):1055–1059.
  • Smeets NA, Prudon M, Winkens B, et al. Fetal volume measurements with three dimensional ultrasound in the first trimester of pregnancy, related to pregnancy outcome, a prospective cohort study. BMC Pregnancy Childb. 2012;12:38.
  • Smeets NA, Winkens B, Prudon M, et al. The predictive value of first trimester fetal volume measurements, a prospective cohort study. Early Hum Dev. 2013;89(5):321–326.
  • Habayeb O, Daemen A, Timmerman D, et al. The relationship between first trimester fetal growth, pregnancy-associated plasma protein A levels and birthweight. Prenat Diagn. 2010;30(9):873–878.
  • Mongelli M, Reid S, Sankaralingam K, et al. Is there a correlation between birth weights and first-trimester crown-rump length growth velocity? J Matern-Fetal Neonatal Med. 2012;25(10):1924–1926.
  • Hoopmann M, Schermuly S, Abele H, et al. First trimester pregnancy volumes and subsequent small for gestational age fetuses. Arch Gynecol Obstet. 2014;290(1):41–46.
  • Rousian M, Hop WC, Koning AH, et al. First trimester brain ventricle fluid and embryonic volumes measured by three-dimensional ultrasound with the use of I-Space virtual reality. Hum Reprod. 2013;28(5):1181–1189.
  • Wang HS, Lim J, English J, et al. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol. 1991;129(3):459–464.
  • Sifakis S, Akolekar R, Kappou D, et al. Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11–13 weeks’ gestation in pregnancies delivering small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol. 2012;161(1):30–33.
  • Murray PG, Clayton PE. Endocrine control of growth. Am J Med Genet C Semin Med Genet. 2013;163C(2):76–85.
  • Hauge-Evans AC, Richardson CC, Milne HM, et al. A role for kisspeptin in islet function. Diabetologia. 2006;49(9):2131–2135.
  • Schwetz TA, Reissaus CA, Piston DW. Differential stimulation of insulin secretion by GLP-1 and Kisspeptin-10. PLoS One. 2014;9(11):e113020.
  • Silvestre RA, Egido EM, Hernández R, et al. Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas. J Endocrinol. 2008;196(2):283–290.
  • Song WJ, Mondal P, Wolfe A, et al. Glucagon regulates hepatic kisspeptin to impair insulin secretion. Cell Metab. 2014;19(4):667–681.
  • Andreozzi F, Mannino GC, Mancuso E, et al. Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals. PLoS One. 2017;12(6):e0179834.
  • Ziyaraa MA, Hamdan FB, Mousa LR. Correlation of Kisspeptin-10 level and fetal well-being in preeclamptic patients. Taiwan J Obstet Gynecol. 2016;55(6):840–846.
  • Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191(3):964–968.
  • Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynecol. 2008;1(4):170–178.
  • Yang SW, Yu JS. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight. Pediatr Int. 2000;42(1):31–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.